AHR and Hepatic fibrosis: Likewise, although so far only demonstrated in mice, attenuation of the acute phase response by dietary AHR ligands [47], prevention of liver fibrosis by application of ITE [54], or of alcohol-induced liver injury by FICZ [49] further suggest AHR ligands as new therapeutic regimens in liver disease.